Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Devenyi (1972)
Medical aspects of drug abuse.Canadian family physician Medecin de famille canadien, 18 1
(2005)
a mechanism for receptor cross-talk? Mol
J. Ton, G. Gerhardt, M. Friedemann, A. Etgen, Greg Rose, Greg Rose, N. Sharpless, E. Gardner (1988)
The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study.Brain research, 451 1-2
R. Mizrahi, I. Suridjan, M. Kenk, T. George, Alan Wilson, S. Houle, P. Rusjan (2013)
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNONeuropsychopharmacology, 38
S. Borgwardt, P. Allen, S. Bhattacharyya, P. Fusar-Poli, J. Crippa, M. Seal, V. Fraccaro, Z. Atakan, R. Martín-Santos, C. O’Carroll, K. Rubia, P. McGuire (2008)
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response InhibitionBiological Psychiatry, 64
L. Garcı́a-Gil, R. Miguel, R. Muñoz, M. Cebeira, M. Villanúa, J. Ramos, J. Fernández-Ruiz (1997)
Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.Neurotoxicology and teratology, 19 6
Jianping Chen, W. Paredes, Jin Li, Diane Smith, J. Lowinson, E. Gardner (1990)
Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysisPsychopharmacology, 102
Emily Bauer, Alexandria Shelton (2021)
Synthetic CannabinoidsBlackwell's Five‐Minute Veterinary Consult Clinical Companion
M. Scherma, C. Dessì, A. Muntoni, S. Lecca, V. Satta, A. Luchicchi, M. Pistis, L. Panlilio, L. Fattore, S. Goldberg, W. Fratta, P. Fadda (2016)
Adolescent Δ9-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult RatsNeuropsychopharmacology, 41
J. Jentsch, E. Andrusiak, A. Tran, M. Bowers, R. Roth (1997)
Δ9-Tetrahydrocannabinol Increases Prefrontal Cortical Catecholaminergic Utilization and Impairs Spatial Working Memory in the Rat: Blockade of Dopaminergic Effects with HA966Neuropsychopharmacology, 16
C. Williams, P. Rogers, T. Kirkham (1998)
Hyperphagia in pre-fed rats following oral delta9-THC.Physiology & behavior, 65 2
S Spiga, A Lintas, M Migliore, M Diana (2010)
Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependenceAddict. Biol., 15
Bethany Figg (2018)
Substance Abuse and Mental Health Services AdministrationJournal of Consumer Health on the Internet, 22
A. Verty, I. McGregor, P. Mallet (2004)
The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinolBrain Research, 1020
M Navarro (1993)
Motor disturbances induced by an acute dose of Δ9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterationsPharmacol. Biochem. Behav., 45
C. Cadoni, N. Simola, E. Espa, S. Fenu, G. Chiara (2015)
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 ratsAddiction Biology, 20
C. Aulakh, A. Bhattacharyya, M. Hossain, S. Pradhan (1980)
Behavioral and neurochemical effects of repeated administration of Δ9-tetrahydrocannabinol in ratsNeuropharmacology, 19
M. Forti, Hannah Sallis, F. Allegri, A. Trotta, L. Ferraro, S. Stilo, A. Marconi, C. Cascia, T. Marques, C. Pariante, P. Dazzan, V. Mondelli, A. Paparelli, A. Kolliakou, D. Prata, F. Gaughran, A. David, C. Morgan, D. Ståhl, M. Khondoker, J. MacCabe, R. Murray (2014)
Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.Schizophrenia bulletin, 40 6
D. Cherek, S. Lane, D. Dougherty (2002)
Possible amotivational effects following marijuana smoking under laboratory conditions.Experimental and clinical psychopharmacology, 10 1
M. Diana, M. Melis, A. Muntoni, G. Gessa (1998)
Mesolimbic dopaminergic decline after cannabinoid withdrawal.Proceedings of the National Academy of Sciences of the United States of America, 95 17
F. Leweke, D. Piomelli, D. Piomelli, F. Pahlisch, F. Pahlisch, D. Muhl, D. Muhl, C. Gerth, C. Hoyer, C. Hoyer, J. Klosterkötter, M. Hellmich, D. Koethe, D. Koethe (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophreniaTranslational Psychiatry, 2
A. Bloom, W. Dewey (1978)
A comparison of some pharmacological actions of morphine and Δ9-tetrahydrocannabinol in the mousePsychopharmacology, 57
N. Volkow, J. Swanson, A. Evins, L. DeLisi, M. Meier, R. Gonzalez, M. Bloomfield, H. Curran, R. Baler (2016)
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review.JAMA psychiatry, 73 3
M. Ranganathan, D. D’Souza (2006)
The acute effects of cannabinoids on memory in humans: a reviewPsychopharmacology, 188
C. Wiers, E. Shokri-Kojori, Christopher Wong, A. Abi-Dargham, Ş. Demiral, D. Tomasi, Gene-Jack Wang, N. Volkow (2016)
Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in MalesNeuropsychopharmacology, 41
S. Lecca, M. Melis, A. Luchicchi, A. Muntoni, M. Pistis (2012)
Inhibitory Inputs from Rostromedial Tegmental Neurons Regulate Spontaneous Activity of Midbrain Dopamine Cells and Their Responses to Drugs of AbuseNeuropsychopharmacology, 37
J. Romero, R. Miguel, E. Garcı́a-Palomero, J. Fernández-Ruiz, J. Ramos (1995)
Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal functionBrain Research, 694
O. Howes, J. Kambeitz, Euitae Kim, D. Ståhl, M. Slifstein, A. Abi-Dargham, S. Kapur (2012)
The nature of dopamine dysfunction in schizophrenia and what this means for treatment.Archives of general psychiatry, 69 8
J. Jentsch, C. Verrico, D. Le, R. Roth (1998)
Repeated exposure to Δ 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the ratNeuroscience Letters, 246
M. SolomonH.Snyder, Wilkins Co, Vol, No 194, Shailesh Banebjee, R. Mechoulam, SoLoroN P., H. Snyder (1975)
Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.The Journal of pharmacology and experimental therapeutics, 194 1
M. Koch, Luis Varela, Jae Kim, J. Kim, Francisco Hernández-Nuño, Stephanie Simonds, C. Castorena, C. Vianna, J. Elmquist, Y. Morozov, P. Rakic, I. Bechmann, M. Cowley, Klara Szigeti-Buck, M. Dietrich, Xiao-Bing Gao, S. Diano, T. Horvath (2015)
Hypothalamic POMC neurons promote cannabinoid-induced feedingNature, 519
A. Bonnin, R. Miguel, M. Hernández, J. Ramos, J. Fernández-Ruiz (1995)
The prenatal exposure to delta 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development.Life sciences, 56 23-24
S. Bhattacharyya, P. Morrison, P. Fusar-Poli, R. Martín-Santos, S. Borgwardt, T. Winton-Brown, C. Nosarti, C. Carroll, M. Seal, P. Allen, M. Mehta, J. Stone, N. Tunstall, V. Giampietro, S. Kapur, R. Murray, A. Zuardi, J. Crippa, Z. Atakan, P. McGuire (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and PsychopathologyNeuropsychopharmacology, 35
N. Urban, M. Slifstein, Judy Thompson, Xiaoyan Xu, R. Girgis, S. Raheja, M. Haney, A. Abi-Dargham (2012)
Dopamine Release in Chronic Cannabis Users: A [11C]Raclopride Positron Emission Tomography StudyBiological Psychiatry, 71
M. Heien, Amina Khan, J. Ariansen, J. Cheer, Paul Phillips, Paul Phillips, K. Wassum, R. Wightman (2005)
Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats.Proceedings of the National Academy of Sciences of the United States of America, 102 29
E. Castañeda, D. Moss, S. Oddie, I. Whishaw (1991)
THC does not affect striatal dopamine release: Microdialysis in freely moving ratsPharmacology Biochemistry and Behavior, 40
M. Bloomfield, C. Morgan, S. Kapur, H. Curran, O. Howes (2014)
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging studyPsychopharmacology, 231
N. Volkow, H. Gillespie, N. Mullani, L. Tancredi, C. Grant, Allan Valentine, L. Hollister (1996)
Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxicationPsychiatry Research: Neuroimaging, 67
C. Hunault, J. Eijkeren, T. Mensinga, I. Vries, Marianne Leenders, J. Meulenbelt (2010)
Disposition of smoked cannabis with high Δ(9)-tetrahydrocannabinol content: a kinetic model.Toxicology and applied pharmacology, 246 3
M. Hershkowitz, H. Szechtman (1979)
Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.European journal of pharmacology, 59 3-4
Xiaofang Wu, E. French (2000)
Effects of chronic Δ9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessmentNeuropharmacology, 39
M. Forti, C. Iyegbe, Hannah Sallis, A. Kolliakou, M. Falcone, A. Paparelli, M. Sirianni, C. Cascia, S. Stilo, T. Marques, R. Handley, V. Mondelli, P. Dazzan, C. Pariante, A. David, C. Morgan, J. Powell, R. Murray (2012)
Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis UsersBiological Psychiatry, 72
D. Fergusson, L. Horwood, A. Beautrais (2003)
Cannabis and educational achievement.Addiction, 98 12
Barbara Bosier, G. Muccioli, B. Mertens, S. Sarre, Y. Michotte, D. Lambert, E. Hermans (2012)
Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivoNeuropharmacology, 62
(2001)
An Overview of the
(2015)
Do we need an ethics of self-organizing tissue?Nature Methods, 12
O. Mawlawi, D. Martínez, M. Slifstein, A. Broft, Rano Chatterjee, D. Hwang, Yiyun Huang, N. Simpson, K. Ngo, R. Heertum, M. Laruelle (2001)
Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral StriatumJournal of Cerebral Blood Flow & Metabolism, 21
E. French, K. Dillon, Xiaofang Wu (1997)
Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigraNeuroReport, 8
R. Foltin, J. Brady, M. Fischman (1986)
Behavioral analysis of marijuana effects on food intake in humansPharmacology Biochemistry and Behavior, 25
M. Elphick, M. Egertová (2001)
The neurobiology and evolution of cannabinoid signalling.Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 356 1407
C. Hattendorf, M. Hattendorf, H. Coper, M. Fernandes (1977)
Interaction between Δ9-Tetrahydrocannabinol and d-amphetaminePsychopharmacology, 54
Miguel Navarro, J. Fernández-Ruiz, R. Miguel, M. Hernández, M. Cebeira, J. Ramos (1993)
Motor disturbances induced by an acute dose of Δ 9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterationsPharmacology Biochemistry and Behavior, 45
T. Sawaguchi, P. Goldman-Rakic (1991)
D1 dopamine receptors in prefrontal cortex: involvement in working memoryScience, 251
P. Stokes, A. Egerton, B. Watson, A. Reid, J. Lappin, O. Howes, D. Nutt, A. Lingford-Hughes (2012)
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availabilityJournal of Psychopharmacology, 26
J. Howes, P. Osgood (1974)
The effect of delta9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosoma; preparations.Neuropharmacology, 13 12
Michael Smith, David Brink (2018)
: A Review of the
(2015)
Report 2015: Trends and Developments
H. Hell, G. Jager, M. Bossong, A. Brouwer, J. Jansma, L. Zuurman, J. Gerven, R. Kahn, N. Ramsey (2011)
Involvement of the endocannabinoid system in reward processing in the human brainPsychopharmacology, 219
K. Sydow, R. Lieb, H. Pfister, M. Höfler, H. Wittchen (2002)
What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults.Drug and alcohol dependence, 68 1
C. Felder, J. Veluz, H. Williams, E. Briley, L. Matsuda (1992)
Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones.Molecular pharmacology, 42 5
L. Voruganti, P. Slomka, P. Zabel, Adel Mattar, A. Awad (2001)
Cannabis induced dopamine release: an in-vivo SPECT studyPsychiatry Research: Neuroimaging, 107
F. Nava, G. Carta, G. Gessa (2000)
Permissive Role of Dopamine D2 Receptors in the Hypothermia Induced by Δ9-Tetrahydrocannabinol in RatsPharmacology Biochemistry and Behavior, 66
(2008)
Home Office Cannabis Potency Study (Home Office
M Kathmann, K Flau, A Redmer, C Trankle, E Schlicker (2006)
Cannabidiol is an allosteric modulator at μ- and δ-opioid receptorsNaunyn Schmiedebergs Arch. Pharmacol., 372
E French (1997)
Δ9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptorsNeurosci. Lett., 226
D. Benjamin, M. Fossler (2016)
Edible Cannabis Products: It Is Time for FDA OversightThe Journal of Clinical Pharmacology, 56
M. Bossong, B. Berckel, R. Boellaard, L. Zuurman, R. Schuit, A. Windhorst, J. Gerven, N. Ramsey, A. Lammertsma, R. Kahn (2009)
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human StriatumNeuropsychopharmacology, 34
E. Carlini, C. Lindsey, S. Tufik (1977)
CANNABIS, CATECHOLAMINES, RAPID EYE MOVEMENT SLEEP AND AGGRESSIVE BEHAVIOURBritish Journal of Pharmacology, 61
G. Tanda, F. Pontieri, G. Chiara (1997)
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.Science, 276 5321
D. Mokler, S. Robinson, J. Johnson, J. Hong, J. Rosecrans (1987)
Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat.Neurotoxicology and teratology, 9 4
A. Bloom, K. Johnson, W. Dewey (1978)
The effects of cannabinoids on body temperature and brain catecholamine synthesis.Research communications in chemical pathology and pharmacology, 20 1
W. S., E. M., R. S, Ambre J., H. Wit (2002)
Comparison of the subjective effects of Δ9-tetrahydrocannabinol and marijuana in humansPsychopharmacology, 161
B. Kolb, Grazyna Gorny, C. Limebeer, L. Parker (2006)
Chronic treatment with Δ‐9‐tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of ratsSynapse, 60
U. Ungerstedt (1971)
Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.Acta physiologica Scandinavica. Supplementum, 367
MR Elphick, M Egertova (2001)
The neurobiology and evolution of cannabinoid signalling. PhilTrans. R. Soc. Lond. B, 356
J Chen, W Paredes, J Lowinson, E Gardner (1991)
Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis studyNeurosci. Lett., 129
R. Pertwee (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.British journal of pharmacology, 153 2
N. Andén (1972)
Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti‐acetylcholine drugsJournal of Pharmacy and Pharmacology, 24
L. Hollister, H. Gillespie (1975)
Action of delta‐9‐tetrahydrocannabinol An approach to the active metabolite hypothesisClinical Pharmacology & Therapeutics, 18
F. Fonseca, J. Fernández-Ruiz, L. Murphy, M. Cebeira, R. Steger, J. Artke, J. Ramos (1992)
Acute effects of δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areasPharmacology Biochemistry and Behavior, 42
M. Navarro, J. Fernández-Ruiz, R. Miguel, M. Hernández, M. Cebeira, J. Ramos (1993)
An acute dose of δ9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activityBehavioural Brain Research, 57
Chronic THC exposure is associated with reduced dopamine neuron activity in the meso-accumbens
Jennifer Dinieri, Xinyu Wang, Henrietta Szutorisz, S. Spano, J. Kaur, P. Casaccia, D. Dow-Edwards, Y. Hurd (2011)
Maternal Cannabis Use Alters Ventral Striatal Dopamine D2 Gene Regulation in the OffspringBiological Psychiatry, 70
Á. Behan, Magdalena Hryniewiecka, C. O’Tuathaigh, A. Kinsella, M. Cannon, M. Karayiorgou, J. Gogos, J. Waddington, D. Cotter (2012)
Chronic Adolescent Exposure to Delta-9-Tetrahydrocannabinol in COMT Mutant Mice: Impact on Indices of Dopaminergic, Endocannabinoid and GABAergic PathwaysNeuropsychopharmacology, 37
S. Sevy, Gwenn Smith, Yilong Ma, V. Dhawan, T. Chaly, P. Kingsley, S. Kumra, S. Abdelmessih, D. Eidelberg (2008)
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomographyPsychopharmacology, 197
Zlatko Mehmedic, S. Chandra, D. Slade, H. Denham, S. Foster, Amit Patel, S. Ross, I. Khan, M. Elsohly (2010)
Potency Trends of Δ9‐THC and Other Cannabinoids in Confiscated Cannabis Preparations from 1993 to 2008 *Journal of Forensic Sciences, 55
M. Luca, V. Valentini, Zisis Bimpisidis, F. Cacciapaglia, P. Caboni, G. Chiara (2014)
Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens ShellFrontiers in Psychiatry, 5
S. Spiga, Alessandra Lintas, M. Migliore, M. Diana (2010)
PRECLINICAL STUDY: FULL ARTICLE: Altered architecture and functional consequences of the mesolimbic dopamine system in cannabis dependenceAddiction Biology, 15
Paul Berghuis, A. Rajnicek, Y. Morozov, R. Ross, J. Mulder, Gabriella Urbán, K. Monory, G. Marsicano, M. Matteoli, A. Canty, A. Irving, I. Katona, Y. Yanagawa, P. Rakic, B. Lutz, K. Mackie, T. Harkany (2007)
Hardwiring the Brain: Endocannabinoids Shape Neuronal ConnectivityScience, 316
N. Volkow, Gene-Jack Wang, F. Telang, J. Fowler, D. Alexoff, J. Logan, Millard Jayne, Christopher Wong, D. Tomasi (2014)
Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severityProceedings of the National Academy of Sciences, 111
E. Chartoff, H. Connery (2014)
It’s MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine systemFrontiers in Pharmacology, 5
D. Fergusson, J. Boden, L. Horwood (2006)
Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis.Addiction, 101 4
C. Williams, P. Rogers, T. Kirkham (1998)
Hyperphagia in pre-fed rats following oral δ9-THCPhysiology & Behavior, 65
R. Richter (1975)
Medical aspects of drug abuse
Syed Ali, G. Newport, A. Scallet, M. Paule, J. Bailey, W. Slikker (1991)
Chronic marijuana smoke exposure in the rhesus monkey IV: Neurochemical effects and comparison to acute and chronic exposure to delta-9-tetrahydrocannabinol (THC) in ratsPharmacology Biochemistry and Behavior, 40
M. Solinas, Z. Justinova, S. Goldberg, G. Tanda (2006)
Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in ratsJournal of Neurochemistry, 98
Justine Renard, M. Krebs, G. Pen, T. Jay (2014)
Long-term consequences of adolescent cannabinoid exposure in adult psychopathologyFrontiers in Neuroscience, 8
N. Ginovart, B. Tournier, Marcelle Moulin-Sallanon, T. Steimer, V. Ibáñez, P. Millet (2012)
Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal SystemsNeuropsychopharmacology, 37
(2003)
Longitudinal birth cohort study indicating that cannabis use in adolescents and early adults is associated with reduced educational achievement
Y. Avraham, D. Ben-Shushan, A. Breuer, O. Zolotarev, Avital Okon, Nir Fink, V. Katz, E. Berry (2004)
Very low doses of Δ8-THC increase food consumption and alter neurotransmitter levels following weight lossPharmacology Biochemistry and Behavior, 77
P. Goldman-Rakic (1996)
Regional and cellular fractionation of working memory.Proceedings of the National Academy of Sciences of the United States of America, 93 24
Jianping Chen, W. Paredes, J. Lowinson, E. Gardner (1991)
Strain-specific facilitation of dopamine efflux by Δ 9-tetrahydrocannabinol in the nucleus accumbens of rat: An in vivo microdialysis studyNeuroscience Letters, 129
Z. Andrews, D. Erion, Rudolph Beiler, Zhong-Wu Liu, A. Abizaid, J. Zigman, J. Elsworth, J. Savitt, R. DiMarchi, M. Tschoep, R. Roth, Xiao-Bing Gao, T. Horvath (2009)
Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial MechanismThe Journal of Neuroscience, 29
J. Fernández-Ruiz, Mariluz Hernández, J. Ramos (2010)
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS DisordersCNS Neuroscience & Therapeutics, 16
P. Stokes, A. Egerton, B. Watson, A. Reid, G. Breen, A. Lingford-Hughes, D. Nutt, M. Mehta (2010)
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challengeNeuroImage, 52
L. Maître, M. Staehelin, H. Bein (1970)
Effect of an extract of cannabis and of some cannabinols on catecholamine metabolism in rat brain and heartAgents and Actions, 1
R. Mizrahi, M. Kenk, I. Suridjan, I. Boileau, T. George, K. McKenzie, Alan Wilson, S. Houle, P. Rusjan (2014)
Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis UseNeuropsychopharmacology, 39
M. Huestis, D. Gorelick, S. Heishman, K. Preston, R. Nelson, E. Moolchan, R. Frank (2001)
Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.Archives of general psychiatry, 58 4
Max Spaderna, Peter Addy, D. D’Souza (2013)
Spicing things up: synthetic cannabinoidsPsychopharmacology, 228
S. Marinelli, V. Marzo, F. Florenzano, F. Fezza, M. Viscomi, M. Stelt, G. Bernardi, M. Molinari, M. Maccarrone, N. Mercuri (2007)
N-Arachidonoyl-Dopamine Tunes Synaptic Transmission onto Dopaminergic Neurons by Activating both Cannabinoid and Vanilloid ReceptorsNeuropsychopharmacology, 32
Parsons, Hurd (2015)
Endocannabinoid signaling in reward and addiction
M. Paule, R. Allen, J. Bailey, A. Scallet, S. Ali, R. Brown, W. Slikker (1992)
Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding.The Journal of pharmacology and experimental therapeutics, 260 1
C. Leroy, L. Karila, J. Martinot, M. Lukasiewicz, E. Duchesnay, C. Comtat, F. Dollé, A. Benyamina, E. Artiges, M. Ribeiro, M. Reynaud, C. Trichard (2012)
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high‐resolution PET studyAddiction Biology, 17
N. Volkow, N. Volkow, Gene-Jack Wang, J. Fowler, J. Logan, S. Gatley, C. Wong, R. Hitzemann, N. Pappas (1999)
Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors.The Journal of pharmacology and experimental therapeutics, 291 1
M. Poddar, W. Dewey (1980)
Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.The Journal of pharmacology and experimental therapeutics, 214 1
K. Maclean, John Littleton (1977)
Environmental stress as a factor in the response of rat brain catecholamine metabolism to delta8-tetrahydrocannabinol.European journal of pharmacology, 41 2
(2015)
Drug Report 2015: Trends and Developments. European Monitoring Centre for Drugs and Drug Addiction
Prenatal cannabis exposure decreases dopamine receptor D 2 messenger RNA expression in the ventral striatum of offspring in humans
R. Levy, B. Dubois (2006)
Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits.Cerebral cortex, 16 7
P. Stokes, M. Mehta, M. Mehta, H. Curran, G. Breen, P. Grasby (2009)
Can recreational doses of THC produce significant dopamine release in the human striatum?NeuroImage, 48
James Cortright, D. Lorrain, J. Beeler, Wei Tang, P. Vezina (2011)
Previous Exposure to Δ9-Tetrahydrocannibinol Enhances Locomotor Responding to but Not Self-Administration of AmphetamineJournal of Pharmacology and Experimental Therapeutics, 337
Ian Campbell (1976)
THE AMOTIVATIONAL SYNDROME AND CANNABIS USE WITH EMPHASIS ON THE CANADIAN SCENEAnnals of the New York Academy of Sciences, 282
C. Kearn, K. Blake-Palmer, E. Daniel, K. Mackie, M. Glass (2005)
Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?Molecular Pharmacology, 67
M. Pistis, L. Ferraro, Luigi Pira, G. Flore, S. Tanganelli, G. Gessa, P. Devoto (2002)
Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis studyBrain Research, 948
D. Albrecht, P. Skosnik, J. Vollmer, Margaret Brumbaugh, K. Perry, B. Mock, Q. Zheng, Lauren Federici, Elizabeth Patton, Christine Herring, Karmen Yoder (2013)
Striatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.Drug and alcohol dependence, 128 1-2
M. Herkenham, A. Lynn, B. Costa, E. Richfield (1991)
Neuronal localization of cannabinoid receptors in the basal ganglia of the ratBrain Research, 547
R. Pertwee, R. Ross (2002)
Cannabinoid receptors and their ligands.Prostaglandins, leukotrienes, and essential fatty acids, 66 2-3
(2009)
Combined analysis of two previous PET studies showing that acute THC administration causes dopamine release in humans
E. Zamberletti, P. Prini, Simona Speziali, M. Gabaglio, Marta Solinas, D. Parolaro, T. Rubino (2012)
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived ratsNeuroscience, 204
M. Kathmann, K. Flau, A. Redmer, C. Tränkle, E. Schlicker (2006)
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 372
V. Varlet, N. Concha-Lozano, A. Berthet, Grégory Plateel, B. Favrat, Mariangela Cesare, Estelle Lauer, M. Augsburger, Aurélien Thomas, C. Giroud (2016)
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana?Scientific Reports, 6
C. Cadoni, V. Valentini, G. Chiara (2008)
Behavioral sensitization to Δ9‐tetrahydrocannabinol and cross‐sensitization with morphine: differential changes in accumbal shell and core dopamine transmissionJournal of Neurochemistry, 106
D. Arciniegas, C. Anderson, Donald Rojas (2018)
Electrophysiological AssessmentTextbook of Traumatic Brain Injury
D. D’Souza, Gabriel Braley, Rebecca Blaise, M. Vendetti, S. Oliver, B. Pittman, M. Ranganathan, Savita Bhakta, Z. Zimolo, T. Cooper, E. Perry (2008)
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humansPsychopharmacology, 198
F. Nava, G. Carta, G. Gessa (2000)
Permissive role of dopamine D(2) receptors in the hypothermia induced by delta(9)-tetrahydrocannabinol in rats.Pharmacology, biochemistry, and behavior, 66 1
Monique Vallée, S. Vitiello, L. Bellocchio, Etienne Hébert-Chatelain, S. Monlezun, E. Martín-García, F. Kasanetz, G. Baillie, Francesca Panin, A. Cathala, V. Roullot-Lacarrière, Sandy Fabre, D. Hurst, D. Lynch, Derek Shore, V. Deroche-Gamonet, Umberto Spampinato, J. Revest, Rafael Maldonado, P. Reggio, R. Ross, G. Marsicano, Pier Piazza (2014)
Pregnenolone Can Protect the Brain from Cannabis IntoxicationScience, 343
D. Walters, L. Carr (1988)
Perinatal exposure to cannabinoids alters neurochemical development in rat brainPharmacology Biochemistry and Behavior, 29
J. Lindgren, A. Ohlsson, S. Agurell, L. Hollister, H. Gillespie (2004)
Clinical effects and plasma levels of Δ9-Tetrahydrocannabinol (Δ9-THC) in heavy and light users of cannabisPsychopharmacology, 74
J Jentsch, C Verrico, D Le, R Roth (1998)
Repeated exposure to Δ9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the ratNeurosci. Lett., 246
William, W., Fleming (2005)
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
a Kinetic Model
E. Silins, L. Horwood, George Patton, George Patton, D. Fergusson, C. Olsson, D. Hutchinson, E. Spry, J. Toumbourou, J. Toumbourou, L. Degenhardt, W. Swift, C. Coffey, Robert Tait, Robert Tait, P. Letcher, J. Copeland, R. Mattick (2014)
Young adult sequelae of adolescent cannabis use: an integrative analysis.The lancet. Psychiatry, 1 4
M. Bloomfield, M. Bloomfield, C. Morgan, A. Egerton, A. Egerton, S. Kapur, H. Curran, Oliver Howes, Oliver Howes (2014)
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic SymptomsBiological Psychiatry, 75
Garriott Jc, L. King, Robert Forney, Francis Hughes (1967)
Effects of some tetrahydrocannabinols on hexobarbital sleeping time and amphetamine induced hyperactivity in mice.Life sciences, 6 19
(2014)
Summary of National Findings Vol
F. Fonseca, J. Fernández-Ruiz, L. Murphy, M. Cebeira, R. Steger, A. Bartke, J. Ramos (1992)
Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas.Pharmacology, biochemistry, and behavior, 42 2
W. Hooker, Reese Jones (2004)
Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxicationPsychopharmacology, 91
F. Leweke, A. Giuffrida, D. Koethe, D. Schreiber, B. Nolden, L. Kranaster, M. Neatby, Miriam Schneider, C. Gerth, M. Hellmich, J. Klosterkötter, D. Piomelli (2007)
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis useSchizophrenia Research, 94
E. Tunbridge, G. Dunn, R. Murray, Nicole Evans, R. Lister, K. Stumpenhorst, Paul Harrison, P. Morrison, D. Freeman (2015)
Genetic moderation of the effects of cannabis: Catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiencesJournal of Psychopharmacology, 29
Natania Crane, R. Schuster, P. Fusar-Poli, R. Gonzalez (2013)
Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex DifferencesNeuropsychology Review, 23
A. Gifford, E. Gardner, Charles Ashby (1997)
The effect of intravenous administration of delta-9-tetrahydrocannabinol on the activity of A10 dopamine neurons recorded in vivo in anesthetized rats.Neuropsychobiology, 36 2
C. Aulakh, A. Bhattacharyya, M. Hossain, S. Pradhan (1980)
Behavioral and neurochemical effects of repeated administration of delta 9-tetrahydrocannabinol in rats.Neuropharmacology, 19 1
L. Horwood, D. Fergusson, C. Coffey, George Patton, R. Tait, Diana, Smart, P. Letcher, E. Silins, Delyse Hutchinson (2012)
Cannabis and depression: an integrative data analysis of four Australasian cohorts.Drug and alcohol dependence, 126 3
E. Oleson, J. Cheer (2012)
A brain on cannabinoids: the role of dopamine release in reward seeking.Cold Spring Harbor perspectives in medicine, 2 8
Judy Thompson, N. Urban, M. Slifstein, Xiaoyan Xu, L. Kegeles, R. Girgis, Yael Beckerman, J. Harkavy-Friedman, R. Gil, A. Abi-Dargham (2012)
Striatal Dopamine Release in Schizophrenia Comorbid with Substance DependenceMolecular psychiatry, 18
A. Egerton, A. Demjaha, P. McGuire, M. Mehta, O. Howes (2010)
The test–retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic functionNeuroImage, 50
S. Wachtel, M. Elsohly, S. Ross, J. Ambre, H. Wit (2002)
Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.Psychopharmacology, 161 4
M. Bossong, M. Mehta, B. Berckel, O. Howes, R. Kahn, P. Stokes (2015)
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatumPsychopharmacology, 232
W. Mcglothlin, L. West (1968)
The marihuana problem: an overview.The American journal of psychiatry, 125 3
Dopamine release is blunted in chronic human cannabis users
R. Girgis, Xiaoyan Xu, R. Gil, E. Hackett, Najate Ojeil, J. Lieberman, M. Slifstein, A. Abi-Dargham (2015)
Antipsychotic binding to the dopamine-3 receptor in humans: A PET study with [11C]-(+)-PHNOSchizophrenia Research, 168
Impaired endocannabinoid signalling dysregulates synaptic plasticity and increases stress responsivity, negative emotional states and cravings that propel addiction
E. Giessen, J. Weinstein, C. Cassidy, M. Haney, Z. Dong, Rassil Ghazzaoui, Najate Ojeil, L. Kegeles, Xiaoyan Xu, N. Vadhan, N. Volkow, M. Slifstein, A. Abi-Dargham (2016)
Deficits in striatal dopamine release in cannabis dependenceMolecular psychiatry, 22
E. Barkus, P. Morrison, D. Vuletić, J. Dickson, P. Ell, L. Pilowsky, R. Brenneisen, D. Holt, J. Powell, S. Kapur, R. Murray (2011)
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET studyJournal of Psychopharmacology, 25
R. Pertwee (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 153
P. Lomax (1971)
Acute tolerance to the hypothermic effect of marihuana in the rat.Research communications in chemical pathology and pharmacology, 2 2
The effects of Δ9-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, are a pressing concern for global mental health. Patterns of cannabis use are changing drastically owing to legalization, the availability of synthetic analogues (commonly termed spice), cannavaping and an emphasis on the purported therapeutic effects of cannabis. Many of the reinforcing effects of THC are mediated by the dopamine system. Owing to the complexity of the cannabinoid–dopamine interactions that take place, there is conflicting evidence from human and animal studies concerning the effects of THC on the dopamine system. Acute THC administration causes increased dopamine release and neuron activity, whereas long-term use is associated with blunting of the dopamine system. Future research must examine the long-term and developmental dopaminergic effects of THC.
Nature – Springer Journals
Published: Nov 16, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.